Source |
Code |
Name |
Case count |
Share of cases (%) |
PURCH |
PURCH_ATC(A10BA02) |
Metformin |
45959 |
|
REIMB |
REIMB_KELA(103)_ICD10(E11) |
Diabetes, insulin-treated, Non-insulin-dependent diabetes mellitus |
31054 |
|
REIMB |
REIMB_KELA(215)_ICD10(E11) |
Diabetes, non-insulin-treated, Non-insulin-dependent diabetes mellitus |
28407 |
|
PRIM_OUT |
PRIM_OUT_NOT_USED_ICD10(E11) |
Non-insulin-dependent diabetes mellitus. Not used in endpoint definition. POSSIBLY INACCURATE IN COMPLEX ENDPOINTS! |
23029 |
|
OUTPAT |
OUTPAT_ICD10(E119) |
Non-insulin-dependent diabetes mellitus - Without complications |
20353 |
|
PRIM_OUT |
PRIM_OUT_NOT_USED_ICD10(E119) |
Non-insulin-dependent diabetes mellitus - Without complications. Not used in endpoint definition. POSSIBLY INACCURATE IN COMPLEX ENDPOINTS! |
20106 |
|
INPAT |
INPAT_ICD10(E119) |
Non-insulin-dependent diabetes mellitus - Without complications |
18916 |
|
PURCH |
PURCH_ATC(A10BH01) |
Sitagliptin |
13321 |
|
PURCH |
PURCH_ATC(A10BB12) |
Glimepiride |
10110 |
|
PURCH |
PURCH_ATC(A10BK03) |
Empagliflozin |
6568 |
|
INPAT |
INPAT_ICD10(E118) |
Non-insulin-dependent diabetes mellitus - With unspecified complications |
5335 |
|
PRIM_OUT |
PRIM_OUT_NOT_USED_ICD10(E118) |
Non-insulin-dependent diabetes mellitus - With unspecified complications. Not used in endpoint definition. POSSIBLY INACCURATE IN COMPLEX ENDPOINTS! |
5263 |
|
PURCH |
PURCH_ATC(A10BB01) |
Glibenclamide |
5129 |
|
PURCH |
PURCH_ATC(A10BD07) |
Metformin and sitagliptin |
5122 |
|
REIMB |
REIMB_KELA(103)_ICD10(E119) |
Diabetes, insulin-treated, Non-insulin-dependent diabetes mellitus - Without complications |
5004 |
|
REIMB |
REIMB_KELA(215)_ICD10(E119) |
Diabetes, non-insulin-treated, Non-insulin-dependent diabetes mellitus - Without complications |
4872 |
|
PURCH |
PURCH_ATC(A10BH05) |
Linagliptin |
4750 |
|
OUTPAT |
OUTPAT_ICD10(E118) |
Non-insulin-dependent diabetes mellitus - With unspecified complications |
4435 |
|
OUTPAT |
OUTPAT_ICD10(E113) |
Non-insulin-dependent diabetes mellitus - With ophthalmic complications |
3536 |
|
PURCH |
PURCH_ATC(A10BX01) |
Guar gum |
3532 |
|
OUTPAT |
OUTPAT_ICD10(E117) |
Non-insulin-dependent diabetes mellitus - With multiple complications |
3435 |
|
PURCH |
PURCH_ATC(A10BK01) |
Dapagliflozin |
3414 |
|
INPAT |
INPAT_ICD10(E117) |
Non-insulin-dependent diabetes mellitus - With multiple complications |
2973 |
|
REIMB |
REIMB_KELA(285)_ICD10(E11) |
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults), Non-insulin-dependent diabetes mellitus |
2969 |
|
INPAT |
INPAT_ICD10(E1100) |
Non-insulin dependent diabetes diabetic hypoglycaemic coma |
2844 |
|
REIMB |
REIMB_KELA(346)_ICD10(E11) |
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults), Non-insulin-dependent diabetes mellitus |
2764 |
|
PURCH |
PURCH_ATC(A10BG03) |
Pioglitazone |
2683 |
|
PRIM_OUT |
PRIM_OUT_NOT_USED_ICD10(E117) |
Non-insulin-dependent diabetes mellitus - With multiple complications. Not used in endpoint definition. POSSIBLY INACCURATE IN COMPLEX ENDPOINTS! |
2478 |
|
PURCH |
PURCH_ATC(A10BJ02) |
Liraglutide |
2419 |
|
PRIM_OUT |
PRIM_OUT_NOT_USED_ICD10(E112) |
Non-insulin-dependent diabetes mellitus - With renal complications. Not used in endpoint definition. POSSIBLY INACCURATE IN COMPLEX ENDPOINTS! |
2393 |
|
INPAT |
INPAT_ICD9(2500A) |
Diabetes mellitus without mention of complication |
2365 |
|
PURCH |
PURCH_ATC(A10BH02) |
Vildagliptin |
2100 |
|
REIMB |
REIMB_KELA(160)_ICD10(E11) |
exenatide, Non-insulin-dependent diabetes mellitus |
1923 |
|
OUTPAT |
OUTPAT_ICD10(E112) |
Non-insulin-dependent diabetes mellitus - With renal complications |
1870 |
|
DEATH |
DEATH_ICD10(E119) |
Non-insulin-dependent diabetes mellitus - Without complications |
1850 |
|
PRIM_OUT |
PRIM_OUT_NOT_USED_ICD10(E114) |
Non-insulin-dependent diabetes mellitus - With neurological complications. Not used in endpoint definition. POSSIBLY INACCURATE IN COMPLEX ENDPOINTS! |
1832 |
|
OUTPAT |
OUTPAT_ICD10(E1100) |
Non-insulin dependent diabetes diabetic hypoglycaemic coma |
1675 |
|
OUTPAT |
OUTPAT_ICD10(E11) |
Non-insulin-dependent diabetes mellitus |
1628 |
|
PRIM_OUT |
PRIM_OUT_NOT_USED_ICD10(E113) |
Non-insulin-dependent diabetes mellitus - With ophthalmic complications. Not used in endpoint definition. POSSIBLY INACCURATE IN COMPLEX ENDPOINTS! |
1614 |
|
PURCH |
PURCH_ATC(A10BD03) |
Metformin and rosiglitazone |
1510 |
|
PURCH |
PURCH_ATC(A10BG02) |
Rosiglitazone |
1468 |
|
OUTPAT |
OUTPAT_ICD10(E115) |
Non-insulin-dependent diabetes mellitus - With peripheral circulatory complications |
1424 |
|
PURCH |
PURCH_ATC(A10BB07) |
Glipizide |
1384 |
|
PURCH |
PURCH_ATC(A10BX07) |
Liraglutide |
1359 |
|
INPAT |
INPAT_ICD10(E115) |
Non-insulin-dependent diabetes mellitus - With peripheral circulatory complications |
1270 |
|
INPAT |
INPAT_ICD10(E112) |
Non-insulin-dependent diabetes mellitus - With renal complications |
1232 |
|
OUTPAT |
OUTPAT_ICD10(E114) |
Non-insulin-dependent diabetes mellitus - With neurological complications |
1228 |
|
INPAT |
INPAT_ICD10(E11) |
Non-insulin-dependent diabetes mellitus |
1166 |
|
PURCH |
PURCH_ATC(A10BX02) |
Repaglinide |
1137 |
|
PURCH |
PURCH_ATC(A10BX04) |
Exenatide |
1087 |
|
REIMB |
REIMB_KELA(177)_ICD10(E11) |
Insulin glargine 300 U / ml, Non-insulin-dependent diabetes mellitus |
983 |
|
INPAT |
INPAT_ICD10(E113) |
Non-insulin-dependent diabetes mellitus - With ophthalmic complications |
938 |
|
REIMB |
REIMB_KELA(162)_ICD10(E11) |
liraglutide, Non-insulin-dependent diabetes mellitus |
891 |
|
PURCH |
PURCH_ATC(A10BX09) |
Dapagliflozin |
889 |
|
OUTPAT |
OUTPAT_ICD10(E116) |
Non-insulin-dependent diabetes mellitus - With other specified complications |
874 |
|
PURCH |
PURCH_ATC(A10BJ01) |
Exenatide |
840 |
|
PURCH |
PURCH_ATC(A10BJ06) |
Name not found |
829 |
|
PRIM_OUT |
PRIM_OUT_NOT_USED_ICD10(E116) |
Non-insulin-dependent diabetes mellitus - With other specified complications. Not used in endpoint definition. POSSIBLY INACCURATE IN COMPLEX ENDPOINTS! |
785 |
|
PURCH |
PURCH_ATC(A10BD08) |
Metformin and vildagliptin |
769 |
|
INPAT |
INPAT_ICD10(E116) |
Non-insulin-dependent diabetes mellitus - With other specified complications |
704 |
|
REIMB |
REIMB_KELA(285)_ICD10(E119) |
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults), Non-insulin-dependent diabetes mellitus - Without complications |
636 |
|
DEATH |
DEATH_ICD10(E117) |
Non-insulin-dependent diabetes mellitus - With multiple complications |
623 |
|
INPAT |
INPAT_ICD10(E114) |
Non-insulin-dependent diabetes mellitus - With neurological complications |
603 |
|
REIMB |
REIMB_KELA(103)_ICD10(E118) |
Diabetes, insulin-treated, Non-insulin-dependent diabetes mellitus - With unspecified complications |
597 |
|
REIMB |
REIMB_KELA(215)_ICD10(E118) |
Diabetes, non-insulin-treated, Non-insulin-dependent diabetes mellitus - With unspecified complications |
588 |
|
PURCH |
PURCH_ATC(A10BJ05) |
Dulaglutide |
559 |
|
PURCH |
PURCH_ATC(A10BD20) |
Metformin and empagliflozin |
537 |
|
PRIM_OUT |
PRIM_OUT_NOT_USED_ICD10(E115) |
Non-insulin-dependent diabetes mellitus - With peripheral circulatory complications. Not used in endpoint definition. POSSIBLY INACCURATE IN COMPLEX ENDPOINTS! |
509 |
|
REIMB |
REIMB_KELA(346)_ICD10(E119) |
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults), Non-insulin-dependent diabetes mellitus - Without complications |
501 |
|
PURCH |
PURCH_ATC(A10BD15) |
Metformin and dapagliflozin |
438 |
|
PURCH |
PURCH_ATC(A10BD05) |
Metformin and pioglitazone |
428 |
|
DEATH |
DEATH_ICD10(E118) |
Non-insulin-dependent diabetes mellitus - With unspecified complications |
425 |
|
REIMB |
REIMB_KELA(358)_ICD10(E11) |
liraglutide, Non-insulin-dependent diabetes mellitus |
377 |
|
REIMB |
REIMB_KELA(310)_ICD10(E11) |
Orlistat, sibutramine and other major and expensive medicines used to treat obesity, Non-insulin-dependent diabetes mellitus |
362 |
|
OUTPAT |
OUTPAT_ICD10(E111) |
Non-insulin-dependent diabetes mellitus - With ketoacidosis |
360 |
|
INPAT |
INPAT_ICD10(E111) |
Non-insulin-dependent diabetes mellitus - With ketoacidosis |
324 |
|
DEATH |
DEATH_ICD10(E112) |
Non-insulin-dependent diabetes mellitus - With renal complications |
268 |
|
PRIM_OUT |
PRIM_OUT_NOT_USED_ICD10(E1100) |
Non-insulin dependent diabetes diabetic hypoglycaemic coma. Not used in endpoint definition. POSSIBLY INACCURATE IN COMPLEX ENDPOINTS! |
261 |
|
REIMB |
REIMB_KELA(160)_ICD10(E119) |
exenatide, Non-insulin-dependent diabetes mellitus - Without complications |
253 |
|
PURCH |
PURCH_ATC(A10BD11) |
Metformin and linagliptin |
243 |
|
INPAT |
INPAT_ICD9(2507A) |
Diabetes mellitus, Diabetes with peripheral circulatory disorders |
224 |
|
OUTPAT |
OUTPAT_ICD10(E1101) |
Non-insulin dependent diabetes diabetic coma with hyperglycaemia |
205 |
|
REIMB |
REIMB_KELA(162)_ICD10(E119) |
liraglutide, Non-insulin-dependent diabetes mellitus - Without complications |
189 |
|
PURCH |
PURCH_ATC(A10BH03) |
Saxagliptin |
171 |
|
INPAT |
INPAT_ICD9(2505A) |
Diabetes mellitus, Diabetes with ophthalmic manifestations |
163 |
|
INPAT |
INPAT_ICD10(E1109) |
Non-insulin-dependent diabetes mellitus - With coma |
132 |
|
PURCH |
PURCH_ATC(A10BX12) |
Empagliflozin |
120 |
|
REIMB |
REIMB_KELA(285)_ICD10(E117) |
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults), Non-insulin-dependent diabetes mellitus - With multiple complications |
104 |
|
OUTPAT |
OUTPAT_ICD10(E1109) |
Non-insulin-dependent diabetes mellitus - With coma |
100 |
|
REIMB |
REIMB_KELA(358)_ICD10(E119) |
liraglutide, Non-insulin-dependent diabetes mellitus - Without complications |
89 |
|
REIMB |
REIMB_KELA(346)_ICD10(E117) |
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults), Non-insulin-dependent diabetes mellitus - With multiple complications |
87 |
|
REIMB |
REIMB_KELA(103)_ICD10(E112) |
Diabetes, insulin-treated, Non-insulin-dependent diabetes mellitus - With renal complications |
74 |
|
REIMB |
REIMB_KELA(346)_ICD10(E118) |
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults), Non-insulin-dependent diabetes mellitus - With unspecified complications |
74 |
|
DEATH |
DEATH_ICD10(E115) |
Non-insulin-dependent diabetes mellitus - With peripheral circulatory complications |
73 |
|
DEATH |
DEATH_ICD9(2500A) |
Diabetes mellitus without mention of complication |
73 |
|
INPAT |
INPAT_ICD10(E1101) |
Non-insulin dependent diabetes diabetic coma with hyperglycaemia |
73 |
|
REIMB |
REIMB_KELA(215)_ICD10(E112) |
Diabetes, non-insulin-treated, Non-insulin-dependent diabetes mellitus - With renal complications |
72 |
|
REIMB |
REIMB_KELA(285)_ICD10(E118) |
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults), Non-insulin-dependent diabetes mellitus - With unspecified complications |
70 |
|
REIMB |
REIMB_KELA(103)_ICD10(E117) |
Diabetes, insulin-treated, Non-insulin-dependent diabetes mellitus - With multiple complications |
68 |
|
INPAT |
INPAT_ICD9(2503A) |
Diabetes mellitus, Diabetes with other coma |
67 |
|
INPAT |
INPAT_ICD9(2506A) |
Diabetes mellitus, Diabetes with neurological manifestations |
62 |
|
REIMB |
REIMB_KELA(103)_ICD9(E11) |
Diabetes, insulin-treated, Name not found |
62 |
|
REIMB |
REIMB_KELA(103)_ICD10(E114) |
Diabetes, insulin-treated, Non-insulin-dependent diabetes mellitus - With neurological complications |
59 |
|
REIMB |
REIMB_KELA(285)_ICD10(E112) |
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults), Non-insulin-dependent diabetes mellitus - With renal complications |
58 |
|
INPAT |
INPAT_ICD9(2504A) |
Diabetes mellitus, Diabetes with renal manifestations |
57 |
|
REIMB |
REIMB_KELA(215)_ICD10(E114) |
Diabetes, non-insulin-treated, Non-insulin-dependent diabetes mellitus - With neurological complications |
57 |
|
REIMB |
REIMB_KELA(346)_ICD10(E112) |
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults), Non-insulin-dependent diabetes mellitus - With renal complications |
57 |
|
REIMB |
REIMB_KELA(103)_ICD10(E116) |
Diabetes, insulin-treated, Non-insulin-dependent diabetes mellitus - With other specified complications |
56 |
|
REIMB |
REIMB_KELA(177)_ICD10(E119) |
Insulin glargine 300 U / ml, Non-insulin-dependent diabetes mellitus - Without complications |
56 |
|
PURCH |
PURCH_ATC(A10BX03) |
Nateglinide |
55 |
|
REIMB |
REIMB_KELA(215)_ICD10(E117) |
Diabetes, non-insulin-treated, Non-insulin-dependent diabetes mellitus - With multiple complications |
54 |
|
REIMB |
REIMB_KELA(215)_ICD10(E116) |
Diabetes, non-insulin-treated, Non-insulin-dependent diabetes mellitus - With other specified complications |
53 |
|
PRIM_OUT |
PRIM_OUT_NOT_USED_ICD10(E111) |
Non-insulin-dependent diabetes mellitus - With ketoacidosis. Not used in endpoint definition. POSSIBLY INACCURATE IN COMPLEX ENDPOINTS! |
50 |
|
PURCH |
PURCH_ATC(A10BD19) |
Linagliptin and empagliflozin |
50 |
|
PURCH |
PURCH_ATC(A10BH04) |
Alogliptin |
48 |
|
DEATH |
DEATH_ICD10(E116) |
Non-insulin-dependent diabetes mellitus - With other specified complications |
47 |
|
INPAT |
INPAT_ICD9(2508A) |
Diabetes mellitus, Diabetes with other specified manifestations |
41 |
|
PURCH |
PURCH_ATC(A10BD10) |
Metformin and saxagliptin |
38 |
|
REIMB |
REIMB_KELA(285)_ICD10(E113) |
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults), Non-insulin-dependent diabetes mellitus - With ophthalmic complications |
38 |
|
REIMB |
REIMB_KELA(346)_ICD10(E113) |
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults), Non-insulin-dependent diabetes mellitus - With ophthalmic complications |
38 |
|
DEATH |
DEATH_ICD10(E110) |
Name not found |
37 |
|
REIMB |
REIMB_KELA(160)_ICD10(E117) |
exenatide, Non-insulin-dependent diabetes mellitus - With multiple complications |
36 |
|
REIMB |
REIMB_KELA(162)_ICD10(E117) |
liraglutide, Non-insulin-dependent diabetes mellitus - With multiple complications |
36 |
|
DEATH |
DEATH_ICD10(E114) |
Non-insulin-dependent diabetes mellitus - With neurological complications |
34 |
|
REIMB |
REIMB_KELA(103)_ICD10(E113) |
Diabetes, insulin-treated, Non-insulin-dependent diabetes mellitus - With ophthalmic complications |
33 |
|
INPAT |
INPAT_ICD9(2501A) |
Diabetes mellitus, Diabetes with ketoacidosis |
32 |
|
PURCH |
PURCH_ATC(A10BK02) |
Kanagliflozin |
32 |
|
OUTPAT |
OUTPAT_ICD10(E110) |
Name not found |
31 |
|
REIMB |
REIMB_KELA(103)_ICD10(E110) |
Diabetes, insulin-treated, Name not found |
31 |
|
REIMB |
REIMB_KELA(215)_ICD10(E113) |
Diabetes, non-insulin-treated, Non-insulin-dependent diabetes mellitus - With ophthalmic complications |
31 |
|
REIMB |
REIMB_KELA(160)_ICD10(E112) |
exenatide, Non-insulin-dependent diabetes mellitus - With renal complications |
27 |
|
REIMB |
REIMB_KELA(215)_ICD10(E110) |
Diabetes, non-insulin-treated, Name not found |
27 |
|
DEATH |
DEATH_ICD9(2507A) |
Diabetes mellitus, Diabetes with peripheral circulatory disorders |
26 |
|
REIMB |
REIMB_KELA(285)_ICD10(E114) |
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults), Non-insulin-dependent diabetes mellitus - With neurological complications |
26 |
|
REIMB |
REIMB_KELA(162)_ICD10(E112) |
liraglutide, Non-insulin-dependent diabetes mellitus - With renal complications |
24 |
|
REIMB |
REIMB_KELA(346)_ICD10(E114) |
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults), Non-insulin-dependent diabetes mellitus - With neurological complications |
24 |
|
REIMB |
REIMB_KELA(162)_ICD10(E118) |
liraglutide, Non-insulin-dependent diabetes mellitus - With unspecified complications |
22 |
|
DEATH |
DEATH_ICD10(E111) |
Non-insulin-dependent diabetes mellitus - With ketoacidosis |
20 |
|
PRIM_OUT |
PRIM_OUT_NOT_USED_ICD10(E1109) |
Non-insulin-dependent diabetes mellitus - With coma. Not used in endpoint definition. POSSIBLY INACCURATE IN COMPLEX ENDPOINTS! |
20 |
|
REIMB |
REIMB_KELA(103)_ICD10(E111) |
Diabetes, insulin-treated, Non-insulin-dependent diabetes mellitus - With ketoacidosis |
20 |
|
REIMB |
REIMB_KELA(160)_ICD10(E118) |
exenatide, Non-insulin-dependent diabetes mellitus - With unspecified complications |
20 |
|
DEATH |
DEATH_ICD10(E113) |
Non-insulin-dependent diabetes mellitus - With ophthalmic complications |
17 |
|
REIMB |
REIMB_KELA(215)_ICD10(E111) |
Diabetes, non-insulin-treated, Non-insulin-dependent diabetes mellitus - With ketoacidosis |
17 |
|
PURCH |
PURCH_ATC(A10BD09) |
Pioglitazone and alogliptin |
15 |
|
REIMB |
REIMB_KELA(160)_ICD10(E113) |
exenatide, Non-insulin-dependent diabetes mellitus - With ophthalmic complications |
15 |
|
REIMB |
REIMB_KELA(358)_ICD10(E112) |
liraglutide, Non-insulin-dependent diabetes mellitus - With renal complications |
15 |
|
PURCH |
PURCH_ATC(A10BD13) |
Metformin and alogliptin |
14 |
|
PURCH |
PURCH_ATC(A10BJ03) |
Lixisenatide |
14 |
|
REIMB |
REIMB_KELA(285)_ICD10(E116) |
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults), Non-insulin-dependent diabetes mellitus - With other specified complications |
14 |
|
REIMB |
REIMB_KELA(358)_ICD10(E117) |
liraglutide, Non-insulin-dependent diabetes mellitus - With multiple complications |
13 |
|
PURCH |
PURCH_ATC(A10BK04) |
Name not found |
12 |
|
REIMB |
REIMB_KELA(160)_ICD10(E114) |
exenatide, Non-insulin-dependent diabetes mellitus - With neurological complications |
12 |
|
PURCH |
PURCH_ATC(A10BD21) |
Saxagliptin and dapagliflozin |
11 |
|
REIMB |
REIMB_KELA(103)_ICD10(E115) |
Diabetes, insulin-treated, Non-insulin-dependent diabetes mellitus - With peripheral circulatory complications |
11 |
|
REIMB |
REIMB_KELA(162)_ICD10(E113) |
liraglutide, Non-insulin-dependent diabetes mellitus - With ophthalmic complications |
11 |
|
REIMB |
REIMB_KELA(346)_ICD10(E116) |
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults), Non-insulin-dependent diabetes mellitus - With other specified complications |
10 |
|
REIMB |
REIMB_KELA(162)_ICD10(E114) |
liraglutide, Non-insulin-dependent diabetes mellitus - With neurological complications |
9 |
|
REIMB |
REIMB_KELA(215)_ICD10(E115) |
Diabetes, non-insulin-treated, Non-insulin-dependent diabetes mellitus - With peripheral circulatory complications |
9 |
|
REIMB |
REIMB_KELA(310)_ICD10(E119) |
Orlistat, sibutramine and other major and expensive medicines used to treat obesity, Non-insulin-dependent diabetes mellitus - Without complications |
9 |
|
PURCH |
PURCH_ATC(A10BX10) |
Lixisenatid |
8 |
|
REIMB |
REIMB_KELA(177)_ICD10(E118) |
Insulin glargine 300 U / ml, Non-insulin-dependent diabetes mellitus - With unspecified complications |
8 |
|
PURCH |
PURCH_ATC(A10BB02) |
Chlorpropamide |
7 |
|
REIMB |
REIMB_KELA(358)_ICD10(E113) |
liraglutide, Non-insulin-dependent diabetes mellitus - With ophthalmic complications |
7 |
|
REIMB |
REIMB_KELA(160)_ICD10(E116) |
exenatide, Non-insulin-dependent diabetes mellitus - With other specified complications |
6 |
|
DEATH |
DEATH_ICD9(2505A) |
Diabetes mellitus, Diabetes with ophthalmic manifestations |
5 |
|
DEATH |
DEATH_ICD9(2506A) |
Diabetes mellitus, Diabetes with neurological manifestations |
5 |
|
DEATH |
DEATH_ICD9(2508A) |
Diabetes mellitus, Diabetes with other specified manifestations |
5 |
|
INPAT |
INPAT_ICD9(2502A) |
Diabetes mellitus, Diabetes with hyperosmolarity |
5 |
|
REIMB |
REIMB_KELA(103)_ICD8(E11) |
Diabetes, insulin-treated, Name not found |
5 |
|
REIMB |
REIMB_KELA(285)_ICD10(E115) |
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults), Non-insulin-dependent diabetes mellitus - With peripheral circulatory complications |
5 |
|
REIMB |
REIMB_KELA(358)_ICD10(E118) |
liraglutide, Non-insulin-dependent diabetes mellitus - With unspecified complications |
5 |
|